Citation tools

Head, Jonathan F. et al "Abstract A009: Forty-three week follow-up of a phase 1a clinical trial of a PSA, IL-2, GM-CSF containing prostate cancer therapeutic vaccine in PSA defined biochemical recurrent prostate cancer patients." Cancer Immunology Research 7.2 Supplement (2019): A009. Web. 27 Nov. 2021.